Physical Growth and Retinopathy in Preterm Infants: Involvement of IGF-I and GH
- 1 December 2001
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 50 (6) , 732-736
- https://doi.org/10.1203/00006450-200112000-00017
Abstract
GH and IGF-I are important for physical growth. We measured serum levels of these factors in preterm infants. The study population (n = 81) was divided into three groups according to the gestational age. We evaluated differences in serum GH and IGF-I levels among groups with regard to physical growth and development of retinopathy of prematurity. Serum GH levels in extremely preterm infants born at <28 wk of gestational age were significantly higher than levels in those born between 28 and 34 wk at 1 and 2 mo of age. In contrast, serum IGF-I levels in extremely preterm infants remained low, whereas those in the other two groups gradually increased. Evaluation of the effects of GH and IGF-I on physical growth in very low birth weight infants (<1500 g) showed that IGF-I concentrations were positively related to physical growth for several months after birth, whereas no relationship was observed between GH and physical growth. Multivariate analysis demonstrated that high GH concentration at 1 mo of age was significantly associated with development of severe retinopathy of prematurity. In conclusion, persistent low serum IGF-I levels may explain the slow physical growth during neonatal life, and exposure of high GH may cause, at least in part, severe retinopathy of prematurity in preterm infants.Keywords
This publication has 34 references indexed in Scilit:
- Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1, Growth Hormone, and Feeding in the NewbornJournal of Clinical Endocrinology & Metabolism, 1998
- IGF‐I, IGF‐II, free IGF‐I and IGFBP‐1, ‐2 and ‐3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newbornsActa Paediatrica, 1997
- Maternal risk factors for retinopathy of prematurity – a population‐based studyActa Obstetricia et Gynecologica Scandinavica, 1996
- Surfactant replacement therapy: A new risk factor in developing retinopathy of prematurity?European Journal of Pediatrics, 1994
- Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.Journal of Clinical Investigation, 1993
- Role of insulin-like growth factors in embryonic and postnatal growthCell, 1993
- The apparent role of blood transfusions in the development of retinopathy of prematurityEuropean Journal of Pediatrics, 1993
- Perinatal factors associated with retinopathy of prematurityActa Paediatrica, 1993
- Role of Growth Hormone in Diabetes MellitusNew England Journal of Medicine, 1984
- Serum Growth Hormone Levels and the Response of Diabetic Retinopathy to Pituitary AblationBMJ, 1969